Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | ft95n | — |
nerve pain that went from her waist to ankles; burning pain; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of nerve pain in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number ft95n) for prophylaxis. On 01-AUG-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced nerve pain (Verbatim: nerve pain that went from her waist to ankles) and pain burning (Verbatim: burning pain). The outcome of the nerve pain was unknown and the outcome of the pain burning was not reported. It was unknown if the reporter considered the nerve pain and pain burning to be related to Shingrix. It was unknown if the company considered the nerve pain and pain burning to be related to Shingrix. Additional Information: GSK Receipt Date: 18-SEP-2025 Pharmacist reported that after a first dose, a patient experienced nerve pain that went from her waist to ankles. It was a burning pain.